Literature DB >> 22290971

Involvement of the AcrAB-TolC efflux pump in the resistance, fitness, and virulence of Enterobacter cloacae.

Astrid Pérez1, Margarita Poza, Ana Fernández, Maria del Carmen Fernández, Susana Mallo, María Merino, Soraya Rumbo-Feal, María P Cabral, Germán Bou.   

Abstract

Multidrug efflux pumps have emerged as important mechanisms of antimicrobial resistance in bacterial pathogens. In order to cause infection, pathogenic bacteria require mechanisms to avoid the effects of host-produced compounds, and express efflux pumps may accomplish this task. In this study, we evaluated the effect of the inactivation of AcrAB-TolC on antimicrobial resistance, fitness, and virulence in Enterobacter cloacae, an opportunistic pathogen usually involved in nosocomial infections. Two different clinical isolates of E. cloacae were used, EcDC64 (multidrug resistance overexpressing the AcrAB-TolC efflux pump) and Jc194 (basal AcrAB-TolC expression). The acrA and tolC genes were deleted in strains EcDC64 and Jc194 to produce, respectively, EcΔacrA and EcΔtolC and JcΔacrA and JcΔtolC knockout (KO) derivatives. Antibiotic susceptibility testing was performed with all isolates, and we discovered that these mechanisms are involved in the resistance of E. cloacae to several antibiotics. Competition experiments were also performed with wild-type and isogenic KO strains. The competition index (CI), defined as the mutant/wild-type ratio, revealed that the acrA and tolC genes both affect the fitness of E. cloacae, as fitness was clearly reduced in the acrA and tolC KO strains. The median CI values obtained in vitro and in vivo were, respectively, 0.42 and 0.3 for EcDC64/EcΔacrA, 0.24 and 0.38 for EcDC64/EcΔtolC, 0.15 and 0.11 for Jc194/JcΔacrA, and 0.38 and 0.39 for Jc194/JcΔtolC. Use of an intraperitoneal mouse model of systemic infection revealed reduced virulence in both E. cloacae clinical strains when either the acrA or tolC gene was inactivated. In conclusion, the structural components of the AcrAB-TolC efflux pump appear to play a role in antibiotic resistance as well as environmental adaptation and host virulence in clinical isolates of E. cloacae.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22290971      PMCID: PMC3318359          DOI: 10.1128/AAC.05509-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  37 in total

1.  A rapid method for efficient gene replacement in the filamentous fungus Aspergillus nidulans.

Authors:  M K Chaveroche; J M Ghigo; C d'Enfert
Journal:  Nucleic Acids Res       Date:  2000-11-15       Impact factor: 16.971

2.  EvgA of the two-component signal transduction system modulates production of the yhiUV multidrug transporter in Escherichia coli.

Authors:  Kunihiko Nishino; Akihito Yamaguchi
Journal:  J Bacteriol       Date:  2002-04       Impact factor: 3.490

3.  Comprehensive studies of drug resistance mediated by overexpression of response regulators of two-component signal transduction systems in Escherichia coli.

Authors:  Hidetada Hirakawa; Kunihiko Nishino; Takahiro Hirata; Akihito Yamaguchi
Journal:  J Bacteriol       Date:  2003-03       Impact factor: 3.490

4.  One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products.

Authors:  K A Datsenko; B L Wanner
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

5.  Substrate specificity of the RND-type multidrug efflux pumps AcrB and AcrD of Escherichia coli is determined predominantly by two large periplasmic loops.

Authors:  Christopher A Elkins; Hiroshi Nikaido
Journal:  J Bacteriol       Date:  2002-12       Impact factor: 3.490

6.  Novel macrolide-specific ABC-type efflux transporter in Escherichia coli.

Authors:  N Kobayashi; K Nishino; A Yamaguchi
Journal:  J Bacteriol       Date:  2001-10       Impact factor: 3.490

7.  The putative response regulator BaeR stimulates multidrug resistance of Escherichia coli via a novel multidrug exporter system, MdtABC.

Authors:  Satoshi Nagakubo; Kunihiko Nishino; Takahiro Hirata; Akihito Yamaguchi
Journal:  J Bacteriol       Date:  2002-08       Impact factor: 3.490

8.  Roles of TolC-dependent multidrug transporters of Escherichia coli in resistance to beta-lactams.

Authors:  Kunihiko Nishino; Junko Yamada; Hidetada Hirakawa; Takahiro Hirata; Akihito Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

9.  Critical role of multidrug efflux pump CmeABC in bile resistance and in vivo colonization of Campylobacter jejuni.

Authors:  Jun Lin; Orhan Sahin; Linda Overbye Michel; Qijing Zhang
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

10.  Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa.

Authors:  Yoichi Hirakata; Ramakrishnan Srikumar; Keith Poole; Naomasa Gotoh; Takashi Suematsu; Shigeru Kohno; Shimeru Kamihira; Robert E W Hancock; David P Speert
Journal:  J Exp Med       Date:  2002-07-01       Impact factor: 14.307

View more
  40 in total

1.  Landscape of Resistance-Nodulation-Cell Division (RND)-Type Efflux Pumps in Enterobacter cloacae Complex.

Authors:  François Guérin; Claire Lallement; Christophe Isnard; Anne Dhalluin; Vincent Cattoir; Jean-Christophe Giard
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

Review 2.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

Review 3.  The Great ESKAPE: Exploring the Crossroads of Bile and Antibiotic Resistance in Bacterial Pathogens.

Authors:  Kevin S Gipson; Kourtney P Nickerson; Eliana Drenkard; Alejandro Llanos-Chea; Snaha Krishna Dogiparthi; Bernard B Lanter; Rhianna M Hibbler; Lael M Yonker; Bryan P Hurley; Christina S Faherty
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

Review 4.  Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?

Authors:  Alejandro Beceiro; María Tomás; Germán Bou
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

5.  Polymorphic variation in susceptibility and metabolism of triclosan-resistant mutants of Escherichia coli and Klebsiella pneumoniae clinical strains obtained after exposure to biocides and antibiotics.

Authors:  Tânia Curiao; Emmanuela Marchi; Carlo Viti; Marco R Oggioni; Fernando Baquero; José Luis Martinez; Teresa M Coque
Journal:  Antimicrob Agents Chemother       Date:  2015-03-30       Impact factor: 5.191

6.  Role of smeU1VWU2X Operon in Alleviation of Oxidative Stresses and Occurrence of Sulfamethoxazole-Trimethoprim-Resistant Mutants in Stenotrophomonas maltophilia.

Authors:  Chao-Jung Wu; Tsu-Ting Chiu; Yi-Tsung Lin; Yi-Wei Huang; Li-Hua Li; Tsuey-Ching Yang
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

7.  Mechanisms of Resistance to Aminoglycoside Antibiotics: Overview and Perspectives.

Authors:  Sylvie Garneau-Tsodikova; Kristin J Labby
Journal:  Medchemcomm       Date:  2015-09-21       Impact factor: 3.597

8.  The SmeYZ efflux pump of Stenotrophomonas maltophilia contributes to drug resistance, virulence-related characteristics, and virulence in mice.

Authors:  Yi-Tsung Lin; Yi-Wei Huang; Shiang-Jiuun Chen; Chia-Wei Chang; Tsuey-Ching Yang
Journal:  Antimicrob Agents Chemother       Date:  2015-04-27       Impact factor: 5.191

9.  Antimicrobial efflux pumps and Mycobacterium tuberculosis drug tolerance: evolutionary considerations.

Authors:  John D Szumowski; Kristin N Adams; Paul H Edelstein; Lalita Ramakrishnan
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

10.  Effect of transcriptional activators SoxS, RobA, and RamA on expression of multidrug efflux pump AcrAB-TolC in Enterobacter cloacae.

Authors:  Astrid Pérez; Margarita Poza; Jesús Aranda; Cristina Latasa; Francisco Javier Medrano; María Tomás; Antonio Romero; Iñigo Lasa; Germán Bou
Journal:  Antimicrob Agents Chemother       Date:  2012-09-24       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.